GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ensign Group Inc (NAS:ENSG) » Definitions » 5-Year RORE %

Ensign Group (Ensign Group) 5-Year RORE % : 10.09% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ensign Group 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Ensign Group's 5-Year RORE % for the quarter that ended in Mar. 2024 was 10.09%.

The industry rank for Ensign Group's 5-Year RORE % or its related term are showing as below:

ENSG's 5-Year RORE % is ranked better than
57.53% of 445 companies
in the Healthcare Providers & Services industry
Industry Median: 4.9 vs ENSG: 10.09

Ensign Group 5-Year RORE % Historical Data

The historical data trend for Ensign Group's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensign Group 5-Year RORE % Chart

Ensign Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.30 27.78 26.78 17.21 11.22

Ensign Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.18 16.42 15.77 11.22 10.09

Competitive Comparison of Ensign Group's 5-Year RORE %

For the Medical Care Facilities subindustry, Ensign Group's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ensign Group's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Ensign Group's 5-Year RORE % falls into.



Ensign Group 5-Year RORE % Calculation

Ensign Group's 5-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 3.79-2.21 )/( 16.74-1.08 )
=1.58/15.66
=10.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 5-year before.


Ensign Group  (NAS:ENSG) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Ensign Group 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Ensign Group's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ensign Group (Ensign Group) Business Description

Traded in Other Exchanges
Address
29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA, USA, 92675
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The real estate segment comprises of properties owned by the company and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the services segment.
Executives
Daren Shaw director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Spencer Burton officer: President and COO 29222 RANCHO VIEJO ROAD, SUITE 127, SAN JUAN CAPISTRANO CA 92675
Ann Scott Blouin director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Chad Keetch officer: Executive Vice President 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Christopher R. Christensen director, 10 percent owner, officer: President & CEO 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Suzanne D. Snapper officer: CFO 27101 PUERTA REAL, STE 450, MISSION VIEJO CA 92691
John O Agwunobi director 4800 NORTH SCOTTSDALE ROAD, SCOTTSDALE AZ 85251
Lee A Daniels director 5152 N. EDGEWOOD DRIVE, SUITE 375, PROVO UT 84604
Beverly B. Wittekind officer: VP & General Counsel 27101 PUERTA REAL, STE 450, MISSION VIEJO CA 92691
Barry Port officer: President of a subsidiary 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
John G. Nackel director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Antoinette T. Hubenette director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Malene Davis director 50 F. STREET, NW, SUITE 3300, WASHINGTON DC 92691
Roy E Christensen director, 10 percent owner, officer: Chairman of the Board 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691